The patient's attorney alleged a deficiency against the device resulting in an unspecified adverse outcome.
Product was used for therapeutic treatment.
Preoperative and postoperative diagnosis was recurrent incisional hernia upper midline.
The procedure performed was laparoscopic converted to open recurrent incisional hernia repair with mesh placement, lysis of adhesions, removal of old mesh and resection of part of the small bowel and anastomosis.
The patient experienced surgical revision, recurrence, and infection.
|
This information was received as a part of an extensive mesh litigation submission to medtronic.
The fda was notified of this large complaint receipt.
Due to the volume of complaint information received by medtronic, this resulted in a report beyond the 30 day target.
If information is provided in the future, a supplemental report will be issued.
|
The patient's attorney alleged a deficiency against the device.
The product was used for laparoscopic therapeutic treatment of an open recurrent incisional hernia repair with mesh placement.
It was reported that after implant, the patient experienced recurrence, adhesions, fistula, scarring, and infection.
Post-operative patient treatment included revision surgery, small bowel resection, removal of prior mesh, placement of new permacol mesh, extensive lysis of adhesions with closure of enterocutaneous fistula, small bowel resection with anastomosis, multiple enterotomies, left and right rectus abdominis muscle flaps rotated to the trunk, removal of scar to abdomen, and debridement of abdominal wall.
|